Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)
- Conditions
- Immune Thrombocytopenic Purpura
- Interventions
- Drug: Sym001
- Registration Number
- NCT00718692
- Lead Sponsor
- Symphogen A/S
- Brief Summary
This trial is designed as a multi-centre, single-dose, exploratory dose-finding, open label trial evaluating the safety and efficacy of Sym001 in 4-9 consecutive cohorts. Subjects will receive a single IV dose of Sym001.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 61
- Confirmed presence of thrombocytopenia with platelet count < 30,000/mm3 at the pre-dose visit.
- History of isolated ITP
- RhD-positive serology.
- Previous treatment and response to first line therapy for ITP
- Known clinical picture suggestive of other causes of thrombocytopenia, especially systematic lupus erythematosus,antiphospholipid syndrome, Evans syndrome, immunodeficiency states, lymphoproliferative disorders, liver disease,ingestion of drugs such as quinidine/quinine, heparin and sulfonamides and hereditary thrombocytopenia confirmed by relevant laboratory findings.
- Suspected infection with HIV, Hepatitis C, H. pylori.
- Clinical splenomegaly
- History of abnormal bone marrow examination.
- Ongoing haemorrhage corresponding to a grade 3 or 4 on the WHO bleeding scale.
- Underlying haemolytic condition
- History of splenectomy.
- Subject is pregnant, breast feeding or intends to become pregnant.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Sym001 Patients treated with Sym001
- Primary Outcome Measures
Name Time Method Incidence and severity of Adverse Events (AEs), including Serious Adverse Events (SAEs) 6 weeks post dosing
- Secondary Outcome Measures
Name Time Method Measurements of platelet counts From day 1 through week 6
Trial Locations
- Locations (59)
Reseach Site 4908
๐ฉ๐ชHalle, Germany
Aysha Hospital Pvt. Ltd., 9109
๐ฎ๐ณChennai, India
Apollo Hospital, 9104
๐ฎ๐ณHyderabad, India
Univ Nebraska Med Ctr. UNMC, 1005
๐บ๐ธOmaha, Nebraska, United States
2085 Henry Tecklenburg Drive, 1001
๐บ๐ธCharleston, South Carolina, United States
Research Site 3203
๐ง๐ชBrugge, Belgium
Research Site 3202
๐ง๐ชLeuven, Belgium
St. John's Medical College Hospital, 9106
๐ฎ๐ณBangalore, India
Research Site 4906, 4907
๐ฉ๐ชBerlin, Germany
Research Site 3201
๐ง๐ชYvoir, Belgium
Kasturba Medical College Hospital, 9103
๐ฎ๐ณUdupi, India
Bnai-Zion Medical Center, 9721
๐ฎ๐ฑHaifa, Israel
Rambam Medical Center, 9723
๐ฎ๐ฑHaifa, Israel
Western Galilee - Nahariya Hospital, 9722
๐ฎ๐ฑNahariya, Israel
Rabin Medical Center, 9724
๐ฎ๐ฑPetach Tikva, Israel
Tel-Aviv Sourasky Medical Center, 9726
๐ฎ๐ฑTel Aviv, Israel
Research site 4801
๐ต๐ฑGdansk, Poland
Spitalul Clinic de Urgente Sfantu Spiridon, 4004
๐ท๐ดIasi, Romania
Regional Clinical Hospital of Nizhny Novgorod, 7003
๐ท๐บNizhny Novgorod, Russian Federation
Regional Clinical Hospital na MI Kalinin, 7005
๐ท๐บSamara, Russian Federation
City Hospital #9 Kyiv Clinical Hospital, 3904
๐บ๐ฆKiev, Ukraine
Vinnytsya Regional Clinical Hospital, 3902
๐บ๐ฆVinnytsya, Ukraine
The Edith Wolfson Medical Center, 9725
๐ฎ๐ฑHolon, Israel
"Prof. Dr. Ion Chiricuta" Oncolgy Institute, 4001
๐ท๐ดCluj-Napoca, Romania
Royal Victoria Infirmery, 4404
๐ฌ๐งNewcastle Upon Tyne, United Kingdom
Singleton Hospital, 4405
๐ฌ๐งSwansea, United Kingdom
Research Site 4806
๐ต๐ฑKrakow, Poland
Research Site 4903
๐ฉ๐ชDuisburg, Germany
Research Site 4901
๐ฉ๐ชHannover, Germany
Hospital of the University of Pennsylvania, Site 1002
๐บ๐ธPhiladelphia, Pennsylvania, United States
Research Site 4905
๐ฉ๐ชEssen, Germany
Research Site 4902
๐ฉ๐ชKรถln, Germany
Research Site 4904
๐ฉ๐ชRegensburg, Germany
Narayana Hrudayalaya Hospitals, 9105
๐ฎ๐ณBangalore, India
MS Ramaiah Memorial Hospital, 9108
๐ฎ๐ณBangalore, India
Columbia Asia Referral Hospital-Yeshwanthpur, 9101
๐ฎ๐ณBangalore, India
Research Site 4804
๐ต๐ฑWroclaw, Poland
Hammersmith Hosptial, 4402
๐ฌ๐งLondon, United Kingdom
Research Site 4805
๐ต๐ฑLodz, Poland
Institutul Clinic Fundeni, 4003
๐ท๐ดBucuresti, Romania
Clinical Center Zemun 3803
๐ท๐ธZemun, Serbia
Cherkassy regional oncology center, 3906
๐บ๐ฆCherkassy, Ukraine
Hospital Gregorio Maranon, 3405
๐ช๐ธMadrid, Spain
Research Site 4803
๐ต๐ฑWarszava, Poland
Instytut Hematologii i Transfuzjologii, 4807
๐ต๐ฑWarszawa, Poland
Brasov Country Hospital, 4002
๐ท๐ดBrasov, Romania
Clinical Center Nis 3802
๐ท๐ธNis, Serbia
Research Site 3402
๐ช๐ธValencia, Spain
University College, 4401
๐ฌ๐งLondon, United Kingdom
Research Site 3401
๐ช๐ธMadrid, Spain
Research Site 4802, 4808
๐ต๐ฑWarszawa, Poland
Saint Petersburg State Institution Of Healthcare, 7001
๐ท๐บSt. Petersburg, Russian Federation
State Healthcare Institution Tula Regional Clin. Hosp., 7002
๐ท๐บTula, Russian Federation
Clinical center Vojvodina 3801
๐ท๐ธNovi Sad, Serbia
Reseach Site 3403
๐ช๐ธBarcelona, Spain
Hospital La Princesa, 3404
๐ช๐ธMadrid, Spain
Gusak Academy of AMS Ukraine, 3905
๐บ๐ฆDonetsk, Ukraine
St. James's University Hospital, 4403
๐ฌ๐งLeeds, United Kingdom
Khmelnytskyi Regional Hospital, 3903
๐บ๐ฆKhmelnytskyi, Ukraine